- gly-11 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable Notch binding activity and polypeptide N-acetylgalactosaminyltransferase activity. Predicted to be involved in protein O-linked glycosylation and regulation of Notch signaling pathway. Predicted to be located in Golgi apparatus. Expressed in excretory cell; hypodermis; and pharyngeal cell. Is an ortholog of human GALNT11 (polypeptide N-acetylgalactosaminyltransferase 11).
- C10G8.8 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Expressed in tail. Human CCDC9 enables RNA binding activity. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human CCDC9 (coiled-coil domain containing 9) and CCDC9B (coiled-coil domain containing 9B).
- tbc-9 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable GTPase activator activity. Human ortholog(s) of this gene implicated in nephrotic syndrome type 20. Is an ortholog of several human genes including TBC1D8 (TBC1 domain family member 8); TBC1D9 (TBC1 domain family member 9); and TBC1D9B (TBC1 domain family member 9B).
- T10E9.14 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable mRNA binding activity. Predicted to be located in cytoplasm and nucleus. Predicted to be part of polysome. Human ortholog(s) of this gene implicated in congenital myopathy 9A and congenital myopathy 9B. Is an ortholog of human FXR1 (FMR1 autosomal homolog 1).
- C35D10.12 [Browse genome (BioProject PRJNA13758)] [Search on AGR]
Caenorhabditis elegans Predicted to enable tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity and tRNA binding activity. Predicted to be involved in tRNA methylation and tRNA wobble uridine modification. Predicted to be located in cytoplasm and nucleus. Is an ortholog of human TRMT9B (tRNA methyltransferase 9B (putative)).